WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Now Available: The U.S. Dredge Report 2025 — download today for expert dredging market insights and data → Click Here

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

argenx SE - American Depositary Shares (NQ:ARGX)

749.57 +3.15 (+0.42%)
Streaming Delayed Price Updated: 11:24 AM EDT, Apr 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about argenx SE - American Depositary Shares

< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
News headline image
argenx Highlights Strategic Priorities for 2022
From argenx
Via Business Wire
News headline image
What 8 Analyst Ratings Have To Say About argenx ↗
Within the last quarter, argenx (NASDAQ:ARGX) has observed the following an... 
Via Benzinga
News headline image
65 Biggest Movers From Yesterday ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock... 
Via Benzinga
News headline image
Analyst Ratings For argenx ↗
Analysts have provided the following ratings for argenx (NASDAQ:ARGX) withi... 
Via Benzinga
News headline image
Analyst Ratings For argenx ↗
Analysts have provided the following ratings for argenx (NASDAQ:ARGX) with... 
Via Benzinga
News headline image
38 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF... 
Via Benzinga
News headline image
Argenx's Vyvgart Wins FDA Approval For Autoimmune, Neuromuscular Disease ↗
The FDA has approved Argenx SE's (NASDAQ: ARGX) Vyvgart (efgartigimod alfa-fcab) for generalized myasthenia gravis (gMG) in adult patients who are anti-... 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street; Crude Oil Down 4% ↗
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones tumbled more than 500 points in the previous session. The Federal Reserve, last week... 
Via Benzinga
News headline image
Expert Ratings For argenx ↗
Analysts have provided the following ratings for argenx (NASDAQ:ARGX) with... 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About argenx ↗
Over the past 3 months, 4 analysts have published their opinion on argenx (NASDAQ: 
Via Benzinga
News headline image
5 Stocks To Watch For December 20, 2021 ↗
Some of the stocks that may grab investor focus today are: Wall Street expects Carnival Corporation (NYSE: CCL) to report a quarterly loss at $1.27 per share on revenue of $1.... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Dec. 19-25): Key Events Of Holiday-Shortened Week ↗
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also drew strength from some... 
Via Talk Markets
News headline image
The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week ↗
Biotech stocks reversed course and advanced solidly in the week ending Dec. 17, as an increase in risk aversion pushed investors to buy into defensive stocks. The sector also... 
Via Benzinga
News headline image
argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis
From argenx SE
Via Business Wire
News headline image
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... 
Via Benzinga
News headline image
2 Mid-Cap Biopharma Stocks BofA Securities Recommends For 2022 ↗
Biotech stocks are risky investments and to make a profit informed decision-making is needed. BofA Securities announced its ... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More ↗
Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021 ↗
Upgrades According to Deutsche Bank, the prior rating for Goodyear Tire & Rubber Co (NASD... 
Via Benzinga
News headline image
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates ↗
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for... 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About argenx ↗
Over the past 3 months, 4 analysts have published their opinion on argenx (NASDAQ: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021 ↗
Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE: 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading. Keybanc lowered Arista Networks, Inc. (... 
Via Benzinga
News headline image
Death Cross Looms Over argenx Investors ↗
If history is any guide, there may be trouble ahead for shares of argenx (NASDAQ:ARGX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 29, 2021 ↗
Upgrades For Preferred Bank (NASDAQ: 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers OptiNose (NASDAQ:OPTN) stock rose 17.74% to $3.11 during Friday's pre-market session. The company's market cap stands at $165.7 million. DBV Technologies (... 
Via Benzinga
News headline image
A Peek Into The Markets: US Stock Futures Down; Apple Posts Downbeat Sales ↗
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Dow Jones jumped more than 200 points in the previous session. Investors are awaiting earnings... 
Via Benzinga
Topics Stocks
News headline image
argenx SE (ARGX) Q3 2021 Earnings Call Transcript ↗
ARGX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021 ↗
Upgrades Maxim Group upgraded the previous rating for Indaptus Therapeutics Inc (NASDAQ: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 7, 2021 ↗
Upgrades For State Street Corporation (NYSE: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021 ↗
Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ: 
Via Benzinga
< Previous 1 2
...
9 10 11 12 13 14 15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2026 Diversified Communications. All rights reserved.